07/24/2025
Meet MeV‑NIS: the measles virus re-engineered to hunt down and destroy aggressive blood cancers. One IV dose, and patients—like those battling refractory multiple myeloma—went into full remission. Science meets surprise cure
Everything we have been taught has been a lie. Do your research. Dig. Deep.
Here’s several studies, and there’s more out there!
Remission of disseminated cancer after systemic oncolytic virotherapy (Mayo Clinic Proceedings, 2014):
https://pubmed.ncbi.nlm.nih.gov/24835528/?utm_source=chatgpt.com
Oncolytic measles virus immunotherapy reviews (Cancers, 2021; PMC, 2021):
https://pmc.ncbi.nlm.nih.gov/articles/PMC7867054/
Measles virus encoding sodium‑iodide symporter (MV‑NIS) (Wikipedia summarizing Mayo Clinic data):
https://en.wikipedia.org/wiki/Measles_virus_encoding_the_human_thyroidal_sodium_iodide_symporter